Karen Bartley
Family Medicine · Crawfordville, FLNPI 1760413090
Payments from drug & device makers
Across 162 payments — averaging $16.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$390
- Boehringer Ingelheim$351
- AstraZeneca$307
- Lilly USA, LLC$247
- AbbVie$235
- GSK$180
- plus $967 from 19 others
What the payments were for
- Food & beverage$2,677100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 24 | $390 |
| Boehringer Ingelheim | 18 | $351 |
| AstraZeneca | 19 | $307 |
| Lilly USA, LLC | 22 | $247 |
| AbbVie | 14 | $235 |
| GSK | 10 | $180 |
| Pfizer | 9 | $162 |
| Exact Sciences | 7 | $124 |
| Phathom Pharmaceuticals, Inc. | 5 | $101 |
| Novartis | 5 | $84 |
| Dexcom, Inc. | 4 | $70 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $54 |
| IBSA Pharma Inc. | 3 | $52 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $51 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $45 |
| Sanofi-aventis U.S. LLC | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Amgen | 2 | $31 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Ironshore Pharmaceuticals Inc. | 1 | $17 |
| Philips North America LLC | 1 | $15 |
| Agile Therapeutics, Inc. | 1 | $13 |
| Merck | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $13 |
How this compares
$2,677 in reported general payments places this provider in the 80th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 162 | $179,338 |
| OzempicSemaglutide | 111 | $141,004 |
| TrulicityDulaglutide | 85 | $108,409 |
| JardianceEmpagliflozin | 66 | $84,056 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 104 | $72,732 |
| FarxigaDapagliflozin Propanediol | 63 | $65,815 |
| MounjaroTirzepatide | 53 | $62,216 |
| JanuviaSitagliptin Phosphate | 39 | $49,833 |
| LinzessLinaclotide | 56 | $43,471 |
| TradjentaLinagliptin | 45 | $41,405 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 65 | $41,197 |
| XareltoRivaroxaban | 28 | $29,356 |
| JanumetSitagliptin Phos/Metformin Hcl | 27 | $26,362 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 52 | $25,479 |
| RybelsusSemaglutide | 23 | $24,366 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $162 | $179,338162 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $247 | $170,625138 claims |
| Novo NordiskOzempic, Rybelsus | $390 | $165,370134 claims |
| Boehringer IngelheimJardiance, Tradjenta, Stiolto Respimat | $351 | $131,629123 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $307 | $117,733169 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Incruse Ellipta, Breo Ellipta | $180 | $112,545185 claims |
| MerckJanuvia, Janumet, Janumet Xr | $13 | $89,68179 claims |
| AbbVieLinzess | $235 | $43,47156 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Crawfordville
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
- Dario AltamiranoHialeah$15.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.